Catello Somma
Associate @ TVM Capital Life Science
Munich, Germany
Catello Somma is a Series B investor at TVM Capital Life Science in Munich focused on Medical and Health Care. Catello Somma is the Associate at TVM Capital Life Science. he attended MIP Politecnico di Milano.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Catello Somma invests in
Stages Catello Somma invests in
Countries Catello Somma invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vico Therapeutics
|
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands. | $12.3M / Series B / Jun 24, 2024 |
Co-Investors
About TVM Capital Life Science
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanningdiscovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.
TVM Capital Life Science Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Catello Somma
Associate
|
|||
Hubert Birner
Managing Partner
|
|||
Luc Marengere
Managing Partner
|
|||
Marc Riviere
General Partner
|
|||
Sascha Berger
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Catello Somma invest in?
Catello Somma invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Catello Somma last invest?
The most recent investment recorded for Catello Somma closed in Jun 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
